Characteristics | Coefficient | 95Â % CI | p value | |
---|---|---|---|---|
Lower | Upper | |||
Intercept | 377.6 | 359.38 | 455.58 | <0.001 |
Baseline CD4 | 0.818 | 0.73 | 0.91 | <0.001 |
Baseline age | −5.0 | −6.0 | −3.95 | <0.001 |
Sex of a patient | ||||
 Female | 17.11 | −5.52 | 39.74 | 0.238 |
 Male | 0.0 |  |  |  |
Baseline WHO clinical stage | ||||
 WHO stage 1 and 2 | −15.33 | −48.01 | 17.35 | 0.358 |
 WHO stage 3 and 4 | 0.0 |  |  |  |
Time in treatment | 8.69 | 4.34 | 13.03 | <0.001 |
Functional status (baseline) | ||||
 Working | −19.1 | −29.1 | −9.1 | <0.001 |
 Ambulatory/bedridden | 0.0 |  |  |  |
Functional status × time in treatment | ||||
 Working × time in treatment | 6.59 | 1.49 | 11.68 | 0.011 |
 Ambulatory/bedridden × time in treatment | 0.0 |  |  |  |